Quaker Chemical Faces Analyst Price Target Reductions Amid Market Pressures

Financial analysts have revised their outlook on Quaker Chemical, with Jefferies leading a recent adjustment by lowering its price target for the specialty chemicals provider. This move reflects ongoing challenges within the market that are impacting short-term growth projections for the company.

Despite reducing its target from $167 to $164 per share on Thursday, Jefferies maintained its “Buy” recommendation, indicating sustained confidence in Quaker Chemical’s long-term business trajectory. The bank cited persistently difficult organic growth conditions as the primary reason for the revised target, noting that significant near-term improvement appears unlikely.

The price target adjustment coincides with a 2% reduction in EBITDA forecasts for the years 2025 through 2027. These revised projections suggest increasing—though manageable—market headwinds that are affecting the company’s financial outlook. Market observers anticipate that... Read more...